Innovating the Pink Eye Treatment Landscape

Leading candidate in Phase 2B for the treatment of Acute Infectious Conjunctivitis.

Enhancing Lives Through Better Vision

Okogen is a clinical stage ophthalmic pharmaceutical company. Our lead product is in clinical trials as a “one stop shop” treatment for all forms of acute infectious conjunctivitis, including bacterial and viral.

Pink eye (conjunctivitis) is when the conjunctiva is irritated by a viral or bacterial infection or allergies. Bacterial and viral conjunctivitis are easily spread from person to person.  

– American Academy of Ophthalmology